Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The STING-mediated inflammatory pathway, also known as the cGAS–STING pathway, is a central component of the innate immune system that detects cytosolic DNA and triggers an inflammatory response primarily through the production of type I interferons (IFN-I) and other proinflammatory cytokines. Activation involves cGAS sensing cytosolic DNA, producing cGAMP, which then binds to and activates STING. Activated STING initiates downstream signaling cascades, ultimately leading to the expression of IFN-I genes and other cytokines. While crucial for antiviral defense and tumor suppression, dysregulation of the pathway can contribute to autoimmune diseases and, in some contexts, promote tumor growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STING-Mediated Inflammatory Pathway.